EquityZen Growth Technology Fund LLC - Series 1754
Raised
$130K
Investors
7
Min Invest
$10,003
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1754 is a Delaware pooled investment fund that raised $130K from 7 investors with a $10K minimum investment, filed September 5, 2023. The offering relies on Rule 506(b) and Section 3(c)(1) exemptions. It is part of the EquityZen platform, which operates nearly 1,900 series vehicles focused on pre-IPO secondary market access.
This pre-IPO pooled fund uses the standard 506(b)/3(c)(1) exemption structure common to single-company SPVs targeting accredited investors. The $10K minimum investment threshold and sub-$150K raise are consistent with retail-accessible pre-IPO platforms that aggregate smaller checks into fractional positions in private growth companies.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.